Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against melanoma.

MLA

Mohammed, Eman R., and Ghada F. Elmasry. “Development of Newly Synthesised Quinazolinone-Based CDK2 Inhibitors with Potent Efficacy against Melanoma.” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 37, no. 1, Dec. 2022, pp. 686–700. EBSCOhost, https://doi.org/10.1080/14756366.2022.2036985.

APA

Mohammed, E. R., & Elmasry, G. F. (2022). Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against melanoma. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 686–700. https://doi.org/10.1080/14756366.2022.2036985

Chicago

Mohammed, Eman R, and Ghada F Elmasry. 2022. “Development of Newly Synthesised Quinazolinone-Based CDK2 Inhibitors with Potent Efficacy against Melanoma.” Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1): 686–700. doi:10.1080/14756366.2022.2036985.